OREXO AB NPV revenue breakdown overview

OREXO AB NPV revenue for the last year amounted to 638.80 M SEK, the most of which — 577.70 M SEK — came from its highest performing source at the moment, US Pharma, the year earlier bringing 571.40 M SEK. The greatest contribution to the revenue figure was made by United States — last year it brought OREXO AB NPV 579.90 M SEK, and the year before that — 574.20 M SEK.